Improvements in life expectancy and quality-adjusted life years as a result of chimeric antigen receptor T-cell therapy is dependent upon immediate access to treatment.
A new study attempted to quantify the economic burden of early progression in patients with newly-diagnosed multiple myeloma.
A recent systematic review evaluated whether survivorship care plan delivery has a positive impact on health outcomes and health care delivery for patients with cancer.
The American Society of Clinical Oncology released an update to their guideline for geriatric oncology, focused on the practical assessment and management of vulnerabilities in older patients receiving chemotherapy.
A new study examined post-treatment evaluation methods of head and neck squamous cell carcinoma in the context of advanced imaging and value-based care.
A new study sought to better define real-world initiation, management, and outcomes of patients with chronic lymphocytic leukemia treated with a standard-of-care therapy.
The National Comprehensive Cancer Network has published updates to its clinical practice guidelines for follicular lymphoma and diffuse large B-cell lymphoma.
Nathan R Handley, MD, explains the extent to which unplanned acute hospital care is a concern for the health care system and ways in which care coordination and clinical pathways can help decrease unnecessary spending.
Immune checkpoint inhibitors of programmed cell death 1 protein moved rapidly into clinical practice following US Food and Drug Administration approval, but patients treated in clinical practice were older than those who participated in the pivotal clinical trials.
A recent study sought to determine the factors associated with durable remission after a complete response to CD19-targeting chimeric antigen receptor T-cell therapy in adult patients with B-cell acute lymphoblastic leukemia.